FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer.
about
Gutless adenovirus: last-generation adenovirus for gene therapyMagic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administrationVariability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsEffects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection.Improvements in adenoviral vector technology: overcoming barriers for gene therapy.Biological approaches to improve skeletal muscle healing after injury and diseaseMonophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.Persistence in muscle of an adenoviral vector that lacks all viral genes.Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantationEarly IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitisVirus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant miceLiver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.Coexpression of p21(WAF1/CIP1) in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expression.Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus.Short communication: protection of axotomized retinal ganglion cells by adenovirally delivered BDNF in vivo.Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle.Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid.Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.Efficient infection of mature skeletal muscle with herpes simplex virus vectors by using dextran sulfate as a co-receptor.Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats.Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer.Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants.Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver.Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.Immunity to CRISPR Cas9 and Cas12a therapeutics.Microsphere-liposome complexes protect adenoviral vectors from neutralising antibody without losses in transfection efficiency, in-vitro.Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.Possibilities of Gene Therapies for Cancer
P2860
Q28277560-E6F14842-6B0E-443F-A04D-C65F940F68EBQ33369840-191F48D1-251B-4A56-9137-60DA4D857E45Q33782516-F8793073-51A5-47FB-A7B5-0B7520C8344AQ33783991-4C047606-65B3-4A1E-9CD8-C2CDC9EEFD74Q33817535-85E1A178-17E6-4FF1-A850-938AE4471007Q33818929-AF1E9401-19B2-4108-A848-C10A19030381Q33869825-08D38D71-ED22-4FCF-9808-2B595C3F9607Q34005922-E201A4EB-2F17-4B51-9294-6E742549001DQ35180158-BA4FCD15-5A48-45EE-9340-817C13368F9CQ35554157-BE5A3E5E-2A03-4E73-8841-1925153E85A7Q35596728-1C77C554-FAFD-41BD-B503-356B6352C20CQ35895708-1EB484C4-F187-4449-8147-9B6C45971D1AQ36018705-4B33C7AD-9C2E-4245-B8D8-C3E9CF07A34FQ36145287-E56DC7E7-E23D-4DBB-BF67-F741E78420EFQ36236670-39236DCA-B8D5-41A2-8039-7C289A9167FDQ36514100-3A6DDC47-CE0D-4A75-AB73-581F8E92C8F2Q37242848-134B082B-B107-48F0-8016-3D6F5C9A4490Q37369657-1E35D92C-041F-4C7C-BF87-60DAEF76240CQ40015350-B645C955-6718-4D67-A187-9CE568573484Q40560199-43ADC7D2-C40B-4948-BD9D-0A433D3437E9Q40601029-D7726A02-05A7-4FF3-BD11-0A5FF9992143Q40655745-5B143DC9-62FA-42DE-AD44-9DE2E732449FQ40669254-A3074CD9-7E01-48BC-9B6F-E7FAE8514895Q40840373-6B32AB06-2748-466E-90DD-2F25FA4A5B1EQ40897136-45B15F97-D0CB-42EE-84ED-7EBFC0E11757Q40930997-A860DBDC-5725-4151-880C-82B4045E67D4Q42155781-791EC97B-1EF1-4B6D-B2BF-BC6B022AD4B4Q42477685-A91AE618-1574-49B2-8416-B8631D712619Q44770310-F800F996-CC95-4478-B1FD-60131C482E0EQ45857571-EF1F7302-79C9-4968-8CDC-63FD55F61C8CQ45862335-8E9CBF47-0366-4BA1-A180-1D7242E4AFC8Q45862470-FF171C8D-11A7-4892-9193-2FDCC7EB3A56Q45862517-30026D6C-D0A2-4EE7-BA72-0D576DAEA60EQ45871061-6BAA1DF9-370C-486D-AD78-82F55EAFA47AQ45873745-02E270E5-DB1D-45C6-A45C-2B548015440AQ45879281-EFFC4EF4-3322-4F96-BDAF-46017C3C50A2Q45879455-9EF2A7C1-1E42-45DB-9B2E-3EDEB3C83160Q58125352-F0C51589-6816-465C-AA99-1FE1D3C14A52
P2860
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
FK506 immunosuppression to con ...... ovirus-mediated gene transfer.
@en
type
label
FK506 immunosuppression to con ...... ovirus-mediated gene transfer.
@en
prefLabel
FK506 immunosuppression to con ...... ovirus-mediated gene transfer.
@en
P2093
P1433
P1476
FK506 immunosuppression to con ...... ovirus-mediated gene transfer.
@en
P2093
Guérette B
Kinoshita I
Tremblay JP
Vilquin JT
P304
P356
10.1089/HUM.1995.6.11-1391
P577
1995-11-01T00:00:00Z